Sfoglia per AUTORE
CONCONI A
Collezione ASL Biella

  

Items : 40

End of induction [(18)F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial. in European journal of nuclear medicine and molecular imaging / Eur J Nucl Med Mol Imaging. 2024 May 25. doi: 10.1007/s00259-024-06765-z.

2024
ASL Biella
AOU Alessandria

Pennese E; Perrone T; Liberati AM; Ibatici A; Stefani PM; Vitolo U; Usai SV; Falcinelli F; Gini G; Roti G; Galimberti S; Musto P; Mannina D; Conconi A; Massaia M; Bari A; Arcari A; Califano C; Pavone V; Chiarenza A; Bolis SAM; Bianchi B; Tosi P; Musuraca G; Ladetto M; Barbieri E; Monaco L; Peano S; Franceschetto A; et alii...

IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2024 Mar 26;8(6):1541-1549. doi: 10.1182/bloodadvances.2023011251.

2024
ASL Biella
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Zucca E; Vitolo U; Pisani F; Pinotti G; Dore F; Esposito F; Pirosa MC; Cesaretti M; Bonomini L; Zanni M; Ghiggi C; Liberati AM; Bruna R; Celli M; Annibali O; Cabras MG; Orsucci L; Tani M; Gaidano G; Balzarotti M; Merli F; Tucci A; Vanazzi A; Sassone M; Botto B; Ferreri AJM; Stathis A; Chiappella A; Conconi A; et alii...

Early complete response as a validated surrogate marker in extranodal marginal zone lymphoma systemic therapy. in Blood / Blood. 2024 Feb 1;143(5):422-428. doi: 10.1182/blood.2023020984.

2024
ASL Biella

Bommier C; Zucca E; Chevret S; Conconi A; Nowakowski G; Maurer MJ; Cerhan JR; Thieblemont C; Lambert J;

IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. in Haematologica / Haematologica. 2024 Aug 1;109(8):2564-2573. doi: 10.3324/haematol.2023.283918.

2024
ASL Biella
AOU Alessandria
AOU Città della Salute di Torino

Stathis A; Pirosa MC; Orsucci L; Feugier P; Tani M; Thieblemont C; Zucca E; Luminari S; Borgo E; Ielmini N; Rossi D; Cavalli F; Bertoni F; Landi F; Spina M; Re F; Pietrantuono G; Houot R; Merli M; Devizzi L; Haioun C; Liberati AM; Celli M; Pulsoni A; Angrilli F; Occhini U; Casasnovas RO; Cartron G; Cabras MG; et alii...

Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi. in Hematological oncology / Hematol Oncol. 2023 Oct;41(4):655-662. doi: 10.1002/hon.3184. Epub 2023 May 28.

2023
AO Cuneo
ASL Biella

Gini G; Federico M; Luminari S; Marcheselli L; Catellani H; Skrypets T; Stefani PM; Pastore D; Pennese E; Liberati AM; Ballerini F; Vitolo U; Usai SV; Capponi M; Galimberti S; Perrone T; Re F; Mannina D; Musto P; Conconi A; Bari A; Massaia M; Ghiggi C; Pulsoni A; Musuraca G; Califano C; Merli M; Manni M; Nizzoli ME; et alii...

Rituximab and Lenalidomide (R 2) Vs Rituximab Alone As Maintenance Treatment after Chemoimmunotherapy for Elderly Patients with Relapsed/Refractory Follicular Lymphoma (FL): Final Analysis of Renoir Phase III Study of the Fondazione Italiana Linfomi (FIL) in Blood

2023
ASL Biella

Boccomini C; Botto B; Evangelista A; Zilioli VR; Anastasia A; Cavallo F; Merli F; Zanni M; Tani M; Chiarenza A; Liberati AM; Conconi A; Corradini P; Bari A; Annechini G; Gaidano G; Spina M; Sartori R; Castellino C; Puccini B; Arcari A; Bigliardi S; Matta G; Merli M; Mannina D; Marino D; Galieni P; Ciambelli F; Musuraca G; et alii...

Marsun, a Phase III, Multicenter, Open Label, Randomized, Controlled Study Investigating Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients with Relapsed or Refractory Marginal Zone Lymphoma (R/R MZL) in Blood

2023
ASL Biella

Thieblemont C; Conconi A; Buske C; Luminari S; Dreyling M; da Silva MG; Andre M; Flores M; Brahami-Aissou K; Cony-Makhoul P; Carras S;

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023 in Hematological oncology

2023
ASL Biella

Thieblemont C; Lamy T; Tani M; Krzisch D; Reda G; Tedeschi A; Usai SV; Guarini A; Bijou F; Stathis A; Anastasia A; Devizzi L; Luminari S; Arcaini L; Casasnovas O; Gressin R; André M; Houot R; Bonomini L; Zucca E; Conconi A;

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.

2022
ASL Torino 5
ASL Biella
AO Cuneo
AOU Città della Salute di Torino
ASL Cuneo 1
AOU Novara
AOU Alessandria

Ladetto M; Pilerci S; Pinto A; Ramadan S; Marchesi F; Cavo M; Musto P; Coviello E; Romano A; Passamonti F; Corradini P; Krampera M; Tosi P; Lanza F; Candoni A; Selleri C; Conconi A; Visani G; Vallisa D; Venditti A; Gambacorti-Passerini C; Rigacci L; La Barbera EO; Corso A; Armiento D; Cilloni D; Cardinali V; Galimberti S; Bocchia M; et alii...

Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma. in American journal of hematology / Am J Hematol. 2022 Dec;97(12):1529-1537. doi: 10.1002/ajh.26715. Epub 2022 Sep 19.

2022
ASL Biella

Lossos IS; Zucca E; Cerhan JR; Zhao W; Larson MC; Cascione L; Conconi A; Thieblemont C; Link BK; Reis IM; Habermann TM; Alderuccio JP;

Time to Complete Response within 24 Months As a Good Surrogate Marker of 8 Year-Progression Free Survival in Extranodal Marginal Zone Lymphoma in Blood

2022
ASL Biella

Bommier C; Conconi A; Zucca E; Nowakowski GS; Cerhan JR; Thieblemont C; Lambert J;

Treatment of Relapsed/Refractory Waldenström Macroglobulinemia Patients: Final Clinical and Molecular Results of the Phase II Brb (Bendamustine, Rituximab and Bortezomib) Trial of the Fondazione Italiana Linfomi (FIL) in Blood

2021
AOU Città della Salute di Torino
ASL Biella

Benevolo G; Ferrero S; Villivà N; Castiglione A; Monaco F; Boccomini C; Cabras MG; Califano C; Casula P; Cavallo F; Conconi A; Drandi D; Gaidano G; Gregorini AI; Felici S; Ferrante M; Mannina D; Molinari AL; Musto P; Musuraca G; Merli M; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

Impact of Immunochemotherapy with R-Bendamustine or R-CHOP in the Post-Induction Management of Treatment Naïve Advanced Stage Follicular Lymphoma Patients: A Subset Analysis of the FOLL12 Trial By the Fondazione Italiana Linfomi (FIL) in Blood

2021
AOU Città della Salute di Torino
ASL Biella

Luminari S; Nizzoli ME; Chiarenza A; Mannina D; Tucci A; Boccomini C; Farina L; Olivieri J; Marcheselli L; Ferrero S; Arcaini L; Pulsoni A; Musuraca G; Califano C; Merli M; Bari A; Conconi A; Re F; Balzarotti M; Ladetto M; Patti C; Pinto A; Cabras MG; Musto P; Gini G; Arcari A; Manni M; Versari A; Federico M; et alii...

RESPONSE ADAPTED POST INDUCTION THERAPY IN FOLLICULAR LYMPHOMA: UPDATED RESULTS OF THE FOLL12 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI (FIL) in Haematologica

2021
ASL Biella

Luminari S; Galimberti S; Versari A; Tucci A; Boccomini C; Farina L; Zaja F; Marcheselli L; Ferrero S; Arcaini L; Pulsoni A; Musuraca G; Califano C; Merli M; Bari A; Conconi A; Del Giudice I; Re F; Stefani PM; Usai SV; Perrone T; Gini G; Falini B; Gattei V; Manni M; Ladetto M; Mannina D; Federico M;

NEXT GENERATION SEQUENCING PROVIDES NOVEL MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA: BIOLOGICAL RESULTS FROM FONDAZIONE ITALIANA LINFOMI (FIL) FOLL12 TRIAL in Haematologica

2021
ASL Biella

Genuardi E; Ferrero S; Della Starza I; Grassi S; Bomben R; Mantoan B; Drandi D; Dogliotti I; Alessandria B; Ferrante M; Ragaini S; Civita AM; Ghiggi C; Pulsoni A; Ronconi S; Merli M; Califano C; Castellino C; Bari A; Conconi A; De Novi LA; Del Giudice I; Gattei V; Galimberti S; Luminari S; Ladetto M; Federico M;

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. in The Lancet. Haematology / Lancet Haematol. 2020 Oct;7(10):e737-e745. doi: 10.1016/S2352-3026(20)30251-9. Epub 2020 Aug 13.

2020
AOU Alessandria
ASL Biella
AOU Città della Salute di Torino
ASL Torino 5
AOU Novara

Grossi PA; Corradini P; Pagano L; Corrao G; Bertù L; Franchi M; Visco C; Rigacci L; Armiento D; Pane F; Oberti M; Zappasodi P; Galieni P; Fava C; Candoni A; Venditti A; Pinto A; Marchesi F; Musto P; Federici AB; Olivieri A; Gentile M; Bocchia M; Selleri C; Ortu La Barbera E; Ferrandina C; Di Renzo N; Luppi M; Scattolin AM; et alii...

Early progression of disease predicts shorter survival in MALT lymphoma patients receiving systemic treatment. in Haematologica / Haematologica. 2020 Nov 1;105(11):2592-2597. doi: 10.3324/haematol.2019.237990.

2020
ASL Biella

Zucca E; Johnson PW; Cavalli F; Lopez Guillermo A; Raderer M; Gaidano G; Margiotta Casaluci G; Kiesewetter B; Torri V; Cascione L; Conconi A; Thieblemont C;

Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi. in Journal of geriatric oncology / J Geriatr Oncol. 2020 Jan;11(1):37-40. doi: 10.1016/j.jgo.2019.06.020. Epub 2019 Jul 8.

2020
ASL Biella
AOU Città della Salute di Torino
AOU Novara

Luminari S; Mammi C; Zanni M; Conconi A; Matteucci P; Bari A; Scalone R; Ferrero S; Ferrari A; Molinari AL; Liberati AM; Tani M; Gini G; Merli M; Nassi L; Tucci A; Salvi F; Musuraca G; Cavallo F; Merli F;

ABCL-135: RE-MIND: A Comparison of Tafasitamab (MOR208) + Lenalidomide (L-MIND) Versus Lenalidomide Monotherapy (Real-World Data) in Transplant-Ineligible Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Clinical Lymphoma, Myeloma and Leukemia

2020
ASL Biella
AOU Città della Salute di Torino

Rodgers T; Luigi Zinzani P; Marino D; Frezzato M; Maria Barbui A; Castellino C; Meli E; Conconi A; Cascavilla N; Cavallo F; H Fowler N; Feinberg B; Tillmanns S; Parche S; Fingerle-Rowson G; Winderlich M; Ambarkhane S; Salles G; Nowakowski G;

Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice. in The oncologist / Oncologist. 2019 Sep;24(9):1246-1252. doi: 10.1634/theoncologist.2018-0603. Epub 2019 Apr 2.

2019
ASL Biella
AO Cuneo
AOU Città della Salute di Torino

Zinzani PL; Castellino C; Gaudio F; Argnani L; Zancanella M; Paolini R; Rigacci L; Devizzi L; Monaco F; Romano A; Fama A; Patti C; Musuraca G; Tecchio C; Marino D; Goldaniga MC; Marasca R; Cox MC; Cascavilla N; Conconi A; Balzarotti M; Tani M; Broccoli A; Casadei B; Chiappella A; Visco C;

Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome. in British journal of haematology / Br J Haematol. 2019 Nov;187(4):478-487. doi: 10.1111/bjh.16106. Epub 2019 Aug 5.

2019
ASL Biella
AOU Novara

Zucca E; Gaidano G; Stathis A; Rossi D; Moccia AA; Moia R; Pirosa MC; Nassi L; Winkler J; Cascione L; Margiotta Casaluci G; Conconi A; Vannata B;

Early progression of disease (POD24) as survival predictor in MALT lymphoma in Journal of Clinical Oncology

2019
ASL Biella

Conconi A; Thieblemont C; Cascione L; Torri V; Kiesewetter B; Margiotta-Casaluci G; Gaidano G; Raderer M; Cavalli F; Lopez-Guillermo A; Johnson PWM; Zucca E;

The role of central nervous system prophylaxis and contralateral testis radiotherapy in primary testicular lymphoma: Long term analysis of the phase II IELSG10 study and preliminary results of the IELSG30 study of international extranodal lymphoma study group and fondazione Italiana linfomi in Haematologica

2019
ASL Biella

Chiappella A; Zucca E; Ferreri AJM; Ciccone G; Vanazzi A; Martelli M; Tucci A; Balzarotti M; Merli F; Cabras MG; Nassi L; Pavone V; Storti S; Tani M; Molinari AL; Conconi A; Gomez H; Lopez-Guillermo A; Sarris AH; Ricardi U; Gospodarowicz MK; Cavalli F; Vitolo U;

High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO. in British journal of haematology / Br J Haematol. 2018 Sep;182(6):807-815. doi: 10.1111/bjh.15454. Epub 2018 Jul 9.

2018
ASL Biella

Conconi A; Montoto S; Berthou C; Dreger P; Ifrah N; Wahlin B; Scheid C; Kroschinsky F; Guilhot F; Jindra P; Pohlreich D; Thieblemont C; Haenel A; Held G; Caillot D; Gramatzki M; Bourhis JH; Nicolas-Virelizier E; Bachy E; Wattad M; Didier B; Musso M; Liliana D; Zaja F; Milone G; Boumendil A; Finel H; Avivi I; Arcaini L; et alii...

Novel acquisitions on biology and management of transformed follicular lymphoma. in Hematological oncology / Hematol Oncol. 2018 Oct;36(4):617-623. doi: 10.1002/hon.2508. Epub 2018 Mar 30.

2018
ASL Biella

Zucca E; Minoia C; Conconi A;

Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma. in Blood / Blood. 2018 Jul 12;132(2):179-186. doi: 10.1182/blood-2018-01-826958. Epub 2018 May 2.

2018
ASL Biella

Cozens K; Porro E; Giovanella L; Bellei M; Cavalli F; Conconi A; Stathis A; Di Rocco A; Zinzani PL; Cascione L; Ferreri AJM; Martelli M; Zucca E; Johnson PW; Milan L; Ceriani L;

Outcome of patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) treated with "standard" immunochemotherapy: A large retrospective study from 4 institutions. in Hematological oncology / Hematol Oncol. 2018 Feb;36(1):84-92. doi: 10.1002/hon.2447. Epub 2017 Jun 16.

2018
ASL Biella

Gaidano G; Zucca E; Pinotti G; Hitz F; Stathis A; Aprile von Hohenstaufen K; Iacoboni G; Margiotta-Casaluci G; Cascione L; Diem S; Conconi A; Moccia AA; Gulden-Sala W; Gobba S;

Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals. in Hematological oncology / Hematol Oncol. 2018 Dec;36(5):757-764. doi: 10.1002/hon.2536. Epub 2018 Aug 16.

2018
ASL Biella
AOU Novara

Cavalli F; Gaidano G; Bertoni F; Bernasconi E; Nassi L; Kwee I; Dirnhofer S; Schmid P; Scherrer A; Staehelin C; Novak U; Battegay M; Hasse B; Darling K; Margiotta-Casaluci G; Conconi A; Zucca E;

Efficacy and safety of decitabine against cutaneous granuloblastic sarcoma: a case report. in Annals of hematology / Ann Hematol. 2018 Aug;97(8):1485-1486. doi: 10.1007/s00277-018-3314-9. Epub 2018 Mar 29.

2018
ASL Biella

Liscia D; Conconi A; Patriarca A; Riccomagno P; Mosca-Siez ML; Castelli A;

Clinical and molecular results of the phase II BRB (bendamustine, rituximab and bortezomib) trial of the fondazione italiana linfomi (FIL) for relapsed/refractory waldenström macroglobulinemia patients in Blood

2018
ASL Biella
AOU Città della Salute di Torino

Benevolo G; Ferrero S; Andriani A; Castiglione A; Baraldi A; Boccomini C; Cabras MG; Califano C; Cavallo F; Conconi A; Curreli L; Drandi D; Gaidano G; Felici S; Ferrante M; Mannina D; Merli M; Molinari AL; Musto P; Musuraca G; Rossi FG; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

A MALT lymphoma prognostic index. in Blood / Blood. 2017 Sep 21;130(12):1409-1417. doi: 10.1182/blood-2017-03-771915. Epub 2017 Jul 18.

2017
ASL Biella

Zucca E; Torri V; Cavalli F; Johnson PW; Lopez Guillermo A; Coiffier B; Laszlo D; Martelli M; Gaidano G; Kiesewetter B; Raderer M; Conconi A; Cascione L; Thieblemont C;

Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Jun 10;35(17):1905-1912. doi: 10.1200/JCO.2016.70.6994. Epub 2017 Mar 29.

2017
ASL Biella
AOU Città della Salute di Torino

Thieblemont C; Johnson P; Cavalli F; Mazzucchelli L; Campo E; Jack A; Moreau A; Ponzoni M; Bellei M; Stelitano C; Haioun C; Bosly A; Zachée P; Ferreri AJM; Hohaus S; Torri V; Tilly H; Morschhauser F; Devizzi L; Pinotti G; Guillermo AL; Sebban C; Salles G; Pettengell R; Martelli M; Vitolo U; Tucci A; Martinelli G; Bouabdallah R; et alii...

Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18-FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study. in British journal of haematology / Br J Haematol. 2017 Aug;178(4):588-591. doi: 10.1111/bjh.14728. Epub 2017 May 9.

2017
ASL Biella
AOU Città della Salute di Torino

Johnson PWM; Zucca E; Rigacci L; Giovanella L; Cabras MG; Gotti M; Stelitano C; Botto B; Ferreri AJM; Zinzani PL; Conconi A; Martelli M; Ceriani L;

IELSG-38: A phase II study of chlorambucil in combination with rituximab followed by maintenance therapy with subcutaneous rituximab in patients with extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALT) in Blood

2017
ASL Biella

Luminari S; Cavalli F; Zucca E; Thieblemont C; Molinari AL; Pulsoni A; Ielmini N; Cabras MG; Capochiani E; Califano C; Tilly H; Salvi F; Conconi A; Palombi F; Cavallo F; Gouill SL; Gini G; Ferrari A; Gyan E; Morschhauser F; Coiffier B; Musuraca G; Guieze R; Marino D; Stathis A; Gregorini A; Gressin R; Orsucci L; Perrot A; et alii...

Rate and causes of 5-azacytidine discontinuation and subsequent therapeutic options in 418 MDS patients from the Italian MDS registry of fondazione Italiana sindromi mielodisplastiche (FISM) in Haematologica

2017
ASL Biella
ASL Torino 5
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Mezzabotta M; Conconi AR; Cametti G; Freilone R; Calzamiglia T; Cavaliere M; Gaidano V; Cilloni D; Danise P; Selleri C; Aguzzi C; Finelli C; Poloni A; Allione B; Di Tucci AA; Miglino M; Balleari E; Monagheddu C; Ceccarelli M; Gioia D; Clavio M; Santini V; Gaidano G; Pane F; Angelucci E; Levis A; Goretti R; Musto P;

Reply to the letter to the editor 'Survival in young adults diagnosed with follicular lymphoma' by Calvo et al. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2016 Jun;27(6):1173. doi: 10.1093/annonc/mdw058. Epub 2016 Feb 18.

2016
ASL Biella
AOU Novara

Conconi A; Montoto S; Montserrat E; Zucca E;

Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41). in The oncologist / Oncologist. 2015 Oct;20(10):1149-53. doi: 10.1634/theoncologist.2015-0180. Epub 2015 Aug 12.

2015
ASL Biella

Nowakowski GS; Cavalli F; Habermann TM; Ristow K; Mazzucchelli L; Campo E; Jack A; Pileri SA; Copie-Bergman C; McPhail ED; Thieblemont C; Martinelli G; Martelli M; Johnson PW; Lopez Guillermo A; Gaidano G; Cortelazzo S; Conconi A; Porro E; Pangalis GA; Stathis A; Kalpadakis C; Mian M; Zucca E; Jackson AE;

Life expectancy of young adults with follicular lymphoma. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Nov;26(11):2317-22. doi: 10.1093/annonc/mdv376. Epub 2015 Sep 11.

2015
ASL Biella
AOU Novara

Zucca E; Ghielmini M; Montserrat E; Lister TA; Gribben J; Cavalli F; Gaidano G; Rancoita PM; Moccia A; Bertoni F; Matthews J; Franceschetti S; Coutinho R; Lobetti-Bodoni C; Montoto S; Lopez-Guillermo A; Conconi A;

Histologic transformation in marginal zone lymphomas†. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Nov;26(11):2329-35. doi: 10.1093/annonc/mdv368. Epub 2015 Sep 23.

2015
ASL Biella
AOU Novara

Gaidano G; Zucca E; Ramponi A; Mazzucchelli L; Cavalli F; Stathis A; Moccia AA; Bertoni F; Aprile von Hohenstaufen K; Margiotta-Casaluci G; Conconi A; Franceschetti S;

Clinical activity of everolimus in relapsed/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group. in British journal of haematology / Br J Haematol. 2014 Jul;166(1):69-76. doi: 10.1111/bjh.12845. Epub 2014 Mar 27.

2014
ASL Biella
AOU Novara

Zucca E; Cavalli F; Gaidano G; Stathis A; Porro E; Kiesewetter B; Vitolo U; Martinelli G; Zinzani PL; Arcaini L; Magagnoli M; Ferreri AJ; Devizzi L; Conconi A; Raderer M; Franceschetti S;